SEC Form EFFECT filed by Horizon Technology Finance Corporation
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | June 20, 2024 4:00 P.M. |
Form: | N-2 | ||||||
|
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | June 20, 2024 4:00 P.M. |
Form: | N-2 | ||||||
|
Date | Price Target | Rating | Analyst |
---|---|---|---|
2/28/2024 | Buy → Neutral | Ladenburg Thalmann | |
1/8/2024 | $11.00 | Neutral → Sell | B. Riley Securities |
10/17/2023 | $10.00 | Neutral → Sell | Compass Point |
9/27/2023 | $11.00 → $10.50 | Sell → Neutral | Compass Point |
8/4/2023 | $11.00 | Neutral → Sell | Compass Point |
4/11/2023 | $12.50 | Buy | Ladenburg Thalmann |
12/20/2022 | $11.50 → $10.50 | Mkt Perform → Underperform | Keefe Bruyette |
10/5/2022 | $10.00 | Neutral | Janney |
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
- Second Quarter 2024 Net Investment Income per Share of $0.36; NAV per Share of $9.12 - - Debt Portfolio Yield of 15.9% - - HRZN Ends Quarter with Committed Backlog of $138 Million - - Declares Regular Monthly Distributions Totaling $0.33 per Share through December 2024 - Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced its financial results for the second quarter ended June 30
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon") (the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that it plans to release financial results for the second quarter ended June 30, 2024 on Tuesday, July 30, 2024, after the close of market trading. The Company has scheduled a conference call to discuss the results on Wednesday, July 31, 2024, at 9:00 a.m. ET. The conference call will feature remarks by Robert D. Pomeroy, Jr., Chairman a
- First Quarter 2024 Net Investment Income per Share of $0.38; NAV per Share of $9.64 - - Debt Portfolio Yield of 15.6% - - HRZN Ends Quarter with Committed Backlog of $168 Million - - Declares Regular Monthly Distributions Totaling $0.33 per Share through September 2024 - Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced its financial results for the first quarter ended March 31
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
Ladenburg Thalmann downgraded Horizon Technology Finance from Buy to Neutral
B. Riley Securities downgraded Horizon Technology Finance from Neutral to Sell and set a new price target of $11.00
Compass Point downgraded Horizon Technology Finance from Neutral to Sell and set a new price target of $10.00
- HRZN Originates $11.5 Million of New Loans in Q2 -- HRZN Ends Quarter with Committed Backlog of $138 Million -Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today provided its portfolio update for the second quarter ended June 30, 2024 and an update on the lending platform ("Horizon Platform") of Horizon Technology Finance Management LLC ("HTFM"), its investment adviser."We maintained a thoughtful approach to new in
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced that Horizon Funding II, LLC, Horizon's wholly-owned subsidiary ("HFII"), has closed a $100 million senior secured credit facility led by a large U.S. based insurance company pursuant to which HFII may issue up to $100 million of secured notes. The capacity under the credit facility may be increased to $200 million with the mutual agreemen
Horizon Tech Finance (NASDAQ:HRZN) reported quarterly earnings of $0.38 per share which missed the analyst consensus estimate of $0.40 by 5 percent. This is a 17.39 percent decrease over earnings of $0.46 per share from the same period last year. The company reported quarterly sales of $26.129 million which missed the analyst consensus estimate of $26.596 million by 1.76 percent. This is a 6.81 percent decrease over sales of $28.037 million the same period last year.
Vesta Healthcare, a virtual care provider group for people with home care, today announced the close of $65 million in a Series C round with new debt financing. The equity round was led by Boston-based RA Capital Management, with participation from Oak HC/FT, Chrysalis Ventures, CareCentrix/Walgreens, Nationwide, Kaiser Permanente Ventures, Lux Capital, Generator Ventures, Deerfield Management and others. Debt financing was provided by Horizon Technology Finance Corporation, an affiliate of Monroe Capital. "The home is the last frontier of healthcare, and caregivers are the most vital yet disconnected resource in the delivery system," said Randy Klein, CEO of Vesta Healthcare. "We're pr
FARMINGTON, Conn., June 9, 2021 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon," or the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced that it has appointed Daniel S. Devorsetz as Chief Operating Officer effective immediately. In addition, Devorsetz has concurrently been appointed as Chief Operating Officer of Horizon's external investment advisor, Horizon Technology Finance Management LLC (the "Advisor" or "HTFM"). He currently serves as Chief Investment Of
40-17G - Horizon Technology Finance Corp (0001487428) (Filer)
10-Q - Horizon Technology Finance Corp (0001487428) (Filer)
8-K - Horizon Technology Finance Corp (0001487428) (Filer)
TEMPE, Ariz., Sept. 12, 2024 /PRNewswire/ -- GT Medical Technologies, Inc. ("GT MedTech" or the "Company"), a medical device company with a corporate purpose of improving the lives of patients with brain tumors, today announced it has secured a $35 million venture loan facility, of which $15 million has been initially funded from Horizon Technology Finance Corporation (NASDAQ:HRZN), an affiliate of Monroe Capital. The Company will use the loan proceeds to execute strategic commercial and clinical expansion plans for GammaTile®. These initiatives will drive key corporate object
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced it has provided a $35 million venture loan facility to GT Medical Technologies, Inc. ("GT MedTech"), of which $15 million has been initially funded. GT MedTech, through its innovative flagship product, GammaTile®, offers a proprietary solution to treat brain tumors. GammaTile is a bioresorbable collagen tile embedded with radiation seeds
Vesta Healthcare, a virtual care provider group for people with home care, today announced the close of $65 million in a Series C round with new debt financing. The equity round was led by Boston-based RA Capital Management, with participation from Oak HC/FT, Chrysalis Ventures, CareCentrix/Walgreens, Nationwide, Kaiser Permanente Ventures, Lux Capital, Generator Ventures, Deerfield Management and others. Debt financing was provided by Horizon Technology Finance Corporation, an affiliate of Monroe Capital. "The home is the last frontier of healthcare, and caregivers are the most vital yet disconnected resource in the delivery system," said Randy Klein, CEO of Vesta Healthcare. "We're pr